Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Checkpoint Therapeutics Inc (CKPT)

Checkpoint Therapeutics Inc (CKPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 292,079
  • Shares Outstanding, K 82,742
  • Annual Sales, $ 1,070 K
  • Annual Income, $ -23,080 K
  • 60-Month Beta 1.56
  • Price/Sales 265.49
  • Price/Cash Flow N/A
  • Price/Book 4.67
Trade CKPT with:

Options Overview Details

View History
  • Implied Volatility 140.71%
  • Historical Volatility 46.83%
  • IV Percentile 43%
  • IV Rank 25.57%
  • IV High 418.45% on 03/05/21
  • IV Low 45.31% on 05/03/21
  • Put/Call Vol Ratio 0.46
  • Today's Volume 294
  • Volume Avg (30-Day) 486
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 9,734
  • Open Int (30-Day) 9,860

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.13
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -44.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.88 +17.01%
on 08/25/21
3.56 -5.34%
on 09/24/21
+0.49 (+17.01%)
since 08/24/21
3-Month
2.48 +35.83%
on 08/04/21
3.56 -5.34%
on 09/24/21
+0.46 (+15.81%)
since 06/24/21
52-Week
2.16 +56.02%
on 10/30/20
5.38 -37.32%
on 02/11/21
+0.63 (+22.99%)
since 09/24/20

Most Recent Stories

More News
Checkpoint Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will...

CKPT : 3.37 (-4.53%)
FBIO : 3.54 (+2.91%)
Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will...

CKPT : 3.37 (-4.53%)
FBIO : 3.54 (+2.91%)
Checkpoint Therapeutics Reports Second Quarter 2021 Financial Results

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the second quarter ended June 30, 2021.

CKPT : 3.37 (-4.53%)
FBIO : 3.54 (+2.91%)
Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will...

CKPT : 3.37 (-4.53%)
FBIO : 3.54 (+2.91%)
Thinking about buying stock in Aethlon Medical, Checkpoint Therapeutics, ContextLogic, Clean Energy Fuels, or Solid Biosciences?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AEMD, CKPT, WISH, CLNE, and SLDB.

CLNE : 8.16 (-3.09%)
WISH : 6.02 (-1.87%)
AEMD : 4.20 (-3.89%)
CKPT : 3.37 (-4.53%)
SLDB : 2.67 (-9.80%)
Checkpoint Therapeutics Announces Completion of Enrollment in the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma

-- Top-line results expected in 4Q 2021

CKPT : 3.37 (-4.53%)
FBIO : 3.54 (+2.91%)
Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2021,...

CKPT : 3.37 (-4.53%)
FBIO : 3.54 (+2.91%)
Thinking about buying stock in Rigel Pharmaceuticals, Checkpoint Therapeutics, GT Biopharma, ICICI Bank, or Arbutus Biopharma?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RIGL, CKPT, GTBP, IBN, and ABUS.

ABUS : 4.62 (+1.99%)
GTBP : 7.00 (-5.79%)
RIGL : 3.74 (-3.86%)
CKPT : 3.37 (-4.53%)
IBN : 19.54 (-0.15%)
Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the full-year ended December 31, 2020 and...

CKPT : 3.37 (-4.53%)
FBIO : 3.54 (+2.91%)
Thinking about buying stock in Sify Technologies, Waitr Holdings, Aqua Metals, Seelos Therapeutics, or Checkpoint Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SIFY, WTRH, AQMS, SEEL, and CKPT.

SEEL : 2.09 (-4.57%)
WTRH : 1.0100 (unch)
AQMS : 2.0500 (+3.54%)
CKPT : 3.37 (-4.53%)
SIFY : 3.47 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Checkpoint Therapeutics, Inc. is a clinical stage, immuno oncology biopharmaceutical. It focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Checkpoint Therapeutics, Inc. is headquartered in New...

See More

Key Turning Points

3rd Resistance Point 3.81
2nd Resistance Point 3.68
1st Resistance Point 3.53
Last Price 3.37
1st Support Level 3.25
2nd Support Level 3.12
3rd Support Level 2.97

See More

52-Week High 5.38
Fibonacci 61.8% 4.15
Fibonacci 50% 3.77
Fibonacci 38.2% 3.39
Last Price 3.37
52-Week Low 2.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar